Input Will Drive Trial Design for Lead Cancer Stem Cell-Targeting Program
September...
Posts about
Success Stories
Veristat Congratulates Origin Biosciences for FDA Approval
Veristat Congratulates Origin Biosciences for FDA Approval of Nulibry during the Week of Rare...
Veristat Supported Marketing Applications for 10% of all FDA Novel Drug Approvals in 2020
Strengthening its Track Record of Successful Client Regulatory Approval Outcomes
SOUTHBOROUGH, MA...
Veristat Helps Antibe Therapeutics Complete Their Phase IIB Study During COVID-19
In early 2019, Veristat helped Antibe Therapeutics, a biotech company with a drug platform of...
Veristat Supports Antibe Therapeutics for Pain and Inflammation Study
Upon receiving approval from Health Canada, Antibe Therapeutics selected Veristat to immediately...
Veristat is Recognized on the Inc. 5000 List of America’s Fastest-Growing Private Companies for the 4th Consecutive Year
Veristat’s Continued Innovation of Its Clinical Development Strategies and Services Allow the...
Veristat Recognized for a Third Consecutive Year on the Inc. 5000 List of America’s Fastest-Growing Private Companies
Veristat’s Growth Positively Impacts Our Ability to Help Clients Achieve Regulatory Approval of...
Veristat and AOBiome Establish a Preferred Partnership To Support Ongoing & Impending Clinical Programs
SOUTHBOROUGH, MA – June 19, 2017 – Veristat, a full service Clinical Research Organization (CRO),...
Veristat Congratulates TESARO on the FDA Approval of ZEJULA™
SOUTHBOROUGH, MA – May 30, 2017 – Veristat, a full service Clinical Research Organization (CRO),...